A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma.
J. P. Fruehauf
No relevant relationships to disclose
Z. Eroglu
No relevant relationships to disclose
K. M. Kong
No relevant relationships to disclose
J. G. Jakowatz
No relevant relationships to disclose
W. L. Akerley
No relevant relationships to disclose
W. E. Samlowski
No relevant relationships to disclose